DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20212485

Measles like syndrome after measles and rubella vaccination

Tulsi Prasad

Abstract


National vaccination program (NIS, IAP) provides vaccination for measles and rubella (MR vaccine) for all children below 15 years of age. After vaccination with live attenuated viruses, the virus replicates on a limited scale. Replication may lead to mild symptoms occurring 5-14 days after MR-vaccination including fever, conjunctivitis and rash but sometimes it leads to florid type of severe rashes which are indistinguishable from a wildtype measles infection. A measles like syndrome may occur following MR vaccination, although it seems to be a rare event and therefore as a pediatrician we must take out time to educate and reassurance the parents about this benign nature and so as to avoid unnecessary problems in future. A 14 year old female child was admitted in our hospital with an impressive (florid) rashes, 7 days after MR vaccination in our vaccination clinic. Diagnostic tests were negative for measles and other infections and was discharged after 7 days of nursing and supportive care. Within 14 days after MR vaccination, a child can present with symptoms very similar to a wildtype measles virus infection. The low incidence of wildtype measles infection after MR vaccination, strongly suggests that these symptoms will likely be a reaction to MR vaccination. To elaborate lots of diagnostic procedures may cause the parents a lot of stress and therefore offering nursing care, supportive care and reassurance to parents may be more appropriate and effective in such cases.


Keywords


Measles, Rubella, Florid rashes, Allergic reaction, MR vaccine, Infected conjunctiva

Full Text:

PDF

References


Kliegman RM, Stanton BMD, Geme JS, Schor NF. Nelson Text Book Of Pediatrics. 20th ed. USA: Elsevier; 2015: 450-5.

Paul VK. Ghai Essential Pediatrics. 8th ed. New York: CBS Press; 2017: 213-4.

World Health Organization. Measles vaccine: WHO position paper. Wkly Epidemiology Rec. 2009;84(35):349-60.

Vashishtha VM, Choudhury P, Bansal CP, Gupta SG. Measles control strategies in india: position paper of indian academy of pediatrics. Indian Pediatr. 2013;50(6):561-4.

Measles Catch Up Immunization Campaign- Guidelines for Planning and Implementation. New Delhi: Ministry of Health and Family Welfare, Government of India; 2010.

Vashishtha VM, Yewale VN, Bansal CP, Mehta PJ, Indian Academy of Pediatrics, Advisory Committee on Vaccines and Immunization Practices (ACVIP). IAP perspectives on measles and rubella elimination strategies. Indian Pediatr. 2014;51(9):719-22.

Kraigher A. Monitoring side-effects and adverse events following immunization against measles and mumps in a national vaccination programme in Slovenia from 1982 to 1986. Dissert Med Facult. 1990.

Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J. 1996;15(1):88-90.

Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr. 1993;82(3):267-70.

CDC (1989). Centers for Disease Control and Prevention. Adverse events following immunization. Atlanta, US Department of Health and Human Services, Public Health Service (Surveillance Report no. 3, 1985–1986).